{"id":"W2106467284","doi":"10.1056/nejmoa020696","title":"A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis","year":2003,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1245,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society","keywords":"Natalizumab; Medicine; Multiple sclerosis; Kilogram; Placebo; Gastroenterology; Internal medicine; Randomized controlled trial; Surgery; Urology; Immunology; Pathology; Body weight","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09725850463914495,"score_gpt":0.337780820711581,"score_spread":0.240522316072436,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}